Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sofalcone
- Development stage
- Unknown
- Lead developer
- Taisho Pharmaceutical
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Sofalcone is a synthetic flavonoid and a derivative of sophoradin, originally isolated from the root of the medicinal plant *Sophora subprostrata*. It is classified as a chalcone and functions primarily as a mucosal protective agent for the gastrointestinal tract. Sofalcone is approved in Japan and South Korea for the treatment of gastritis, gastric ulcers, peptic ulcers, and other gastric mucosal lesions. Its mechanism of action includes enhancing mucosal defense by inhibiting prostaglandin degradation enzymes, directly inhibiting growth and adhesion of *Helicobacter pylori*, exhibiting anti-urease activity against this pathogen, reducing production of vacuolating toxin (VT), suppressing interleukin-8 (IL-8) secretion induced by *H. pylori*, and exerting anti-inflammatory effects through covalent targeting of high mobility group box 1 (HMGB1) protein in intestinal epithelial cells[1][2][3][5][6][7][8].
- Brand names
- Solon
- Other names
- SofalconaSofalconum
02
Targets
H. pylori (Helicobacter pylori)UreaseHMGB1 (High mobility group protein B1)HPGD (15-hydroxyprostaglandin dehydrogenase)
Beyond the preview
Go deeper on Sofalcone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sofalcone.